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Abstract
Introduction: Legionella pneumonia can appear with different levels of severity and it can often present with
complications such as acute respiratory distress syndrome.
Case presentation: We report the case of a 44-year-old Caucasian man with Legionella pneumonia with successive
development of severe acute respiratory distress syndrome. During his stay in intensive care the clinical and
radiological situation of the previously observed acute respiratory distress syndrome unexpectedly worsened due
to acute pulmonary eosinophilic infiltrate of iatrogenic origin.
Conclusion: Levofloxacin treatment caused the occurrence of acute eosinophilic infiltrate. Diagnosis was possible
following bronchoscopic examination using bronchoaspirate and transbronchial biopsy.
Introduction
Since the pneumonia epidemic that struck the delegates
of the American Legion Convention in Philadelphia in
1976, Legionella spp. has become a relatively frequent
cause of community acquired pneumonia [1].
Legionella may appear in different forms, from subcli-
nical presentations to Legionnaires’ disease, which has a
mortality rate as high as 30 to 50% in cases of hospital
infections and in cases of complications such as acute
r e s p i r a t o r yd i s t r e s ss y n d r o m e( A R D S ) .T h ef a t a l i t yr a t e
is 5 to 25% even in patients who are immunocompetent
[2].
Other complications are rare, although a significant
number of drugs used in the treatment of Legionella
pneumonia can be associated with the appearance of
pulmonary eosinophilic infiltrates, especially non-steroi-
dal anti-inflammatory drugs (NSAIDs) and antibiotics
[3]. The diagnosis is mainly based on the temporal cor-
relation between the administration of drugs and the
appearance of the clinical condition, but it is often not
easy to determine the etiologic agent with certainty.
This report concerns the case of a man with Legio-
nella pneumonia that evolved into ARDS and then
became complicated with eosinophilic infiltration as an
effect of treatment with levofloxacin. Usually this drug
is safe, though in some cases can cause eosinophilic
pneumonia [4].
Case presentation
A 44-year-old Caucasian man presented to our hospital
for hyperpyrexia (over 39°C) for about a week, with gen-
eral weakness and strong headaches; he had been trea-
ted by his general practitioner with amoxicillin and
clavulanate administrated orally with no improvement.
His case history revealed that he was a smoker (20
packs/year). No other pathologies or trips abroad had
been registered in the last 6 months.
On admission, he had hyperpyrexia (38.9°C), headache,
dry cough, diarrhea, general weakness and sinus tachy-
cardia (100 beats/minute); his oxygen saturation was
95% (no oxygen supplement).
The results of a physical examination of his chest were
reduced vesicular respiration and crackling in the med-
ian axillary line to the left and in front; a chest X-ray
showed extensive inconsistent parenchymal consolida-
tion at the fissure of the left upper lobe (Figure 1A).
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his white blood cell count was 2020 cells/mm
3,t o t a l
bilirubin level was (1.6 mg/dL), he had reduced albumi-
nemia (2.7 g/dL), increased alkaline phosphatase (382
U/L), g-glutamyl transferase (69 U/L) and creatine phos-
phokinase (422 U/L). His serology test results were
negative for Hepatitis B virus, Hepatitis C virus and
HIV. His initial blood culture test results were negative
for aerobic and anaerobic germs and mycetes.
Our patient began treatment with intravenous pipera-
cillin and tazobactam (13.5 g/day) and clarithromycin
orally (1 g/day). On the third day the results of his urin-
ary antigen test were found to be positive for Legionella
serogroup 1, so clarithromycin was suspended and sub-
stituted with intravenous levofloxacin (750 mg/day). We
maintained the piperacillin and tazobactam treatment to
help prevent secondary infection from other Gram-posi-
tive and Gram-negative bacteria.
On the sixth day, his clinical condition worsened.
After consultation with an infectious disease specialist,
we added rifampicin (900 mg/day) to support the levo-
floxacin action against Legionella pneumonia.
On the ninth day he showed respiratory distress (40
breaths/minute). An Arterial Blood Gas analysis in room
air gave the following results: partial O2 pressure (pO2)
of 50 mmHg, partial CO2 pressure (pCO2) of 30 mmHg,
pH 7.50 and oxygen saturation (SaO2) of 86%.
A computed tomography (CT) scan of his chest
revealed multiple areas of parenchymal consolidation in
the entire upper left pulmonary lobe, mixed with
ground-glass areas and abundant pleural effusion. In the
right lung, in the dorsal and basal regions, there were
ground-glass areas mixed with consolidation areas (Fig-
ure 1B).
On the 10th day PaO2/fraction of inspired O2 (FiO2)
ratio was 101 and he was moved to our intensive care
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Figure 1 Chest X-ray and computed tomography (CT) images. A) A chest X-ray taken on admission: extensive pulmonary consolidation can
be seen in the upper left lobe (arrow). There was an absence of pleural effusion and no cardiomegaly. B) A chest CT scan taken on the ninth
day: consolidation areas can be seen on the whole superior left lobe, mixed with ground-glass areas and air bronchogram. There was an
absence of pleural effusion. C, D) A CT scan taken on the 21st day: on the left there is parenchymal consolidation with air bronchogram and
pneumothorax, and several areas of parenchymal consolidation on the right superior lobe. There was an absence of pleural effusion.
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positive airway pressure modality, with noticeable
improvement of the respiratory parameters (PaO2/FiO2
ratio of 254). On the 17th day, levofloxacin was sus-
pended in order to allow wash-out and taking of further
blood cultures. On the 19th day levofloxacin was
resumed; after advice from an infectious diseases specia-
list intravenous levofloxacin 1500 mg per day together
with intravenous fluconazole 800 mg per day were given
On the 21st day, after an initial improvement, he
showed respiratory distress. A CT scan showed
increased parenchymal consolidation with left pneu-
mothorax (Figure 1C, D).
On the 22nd day, because of the unexpected occur-
rence of muscular exhaustion, orotracheal intubation
was performed and he was placed on a mechanical ven-
tilator in synchronized intermittent mandatory ventila-
tion mode associated with appropriate kinetic therapy
on a reclining bed. A fibrobronchoscopy study, carried
out with bronchoalveolar lavage (BAL) for bacteriologi-
cal reasons and in order to define the cytological profile,
revealed the presence of numerous macrophages (32%),
lymphocytes (26%; CD4/CD8 ratio 0.8), neutrophilic
granulocytes (40%) and some eosinophilic granulocytes
(2%). Protozoa, fungus and neoplastic cells were absent.
On the 23rd day, methylprednisolone (120 mg/day
intravenously) was added to the therapy.
On the 26th day, he underwent another bronchoscopy,
with BAL and transbronchial biopsy in the basal seg-
ments of the lower right lobe, which revealed a histolo-
gical condition compatible with acute eosinophilic
pneumonia (Figures 2 and 3). The BAL confirmed the
presence of eosinophils 28%, macrophages 57%, lympho-
cytes 15%, neutrophilic granulocytes 2% and a CD4/CD8
ratio of 1. Incidental findings showed masses of finely
pigmented macrophages (due to our patient’ss m o k i n g
habit). Serum levels of total IgE were within normal lim-
its, and the specific IgE antibody results for allergens
(food, pollen, fungal) were also negative. Fecal and sero-
logical test results were negative for parasites.
On the 27th day, his steroid therapy was increased
(methylprednisolone 1 g/day) while levofloxacin was
suspended. His response to steroid therapy was rapid,
with a general improvement starting from the fifth day
of treatment (the 32nd day overall), associated with
accompanying improvement of respiratory exchange and
subsequent return to spontaneous breathing on the 41st
day (PaO2/FiO2 ratio of 357).
On the 51st day, a chest X-ray showed that the pneu-
monia bilateral consolidation had completely resolved
(Figure 4).
Discussion
ARDS is a common medical emergency and is usually a
complication of a previous illness, which is the etiological
cause [5]. In our patient, the unusual fact was the over-
lapping of acute eosinophilic infiltrate in legionellosis.
Eosinophilic pneumonias include a wide range of pul-
monary pathologies, characterized by alveolar and per-
ipheral blood eosinophilia. Peripheral eosinophilia may
be absent, in particular in the early stages of acute idio-
pathic eosinophilia pneumonia or in patients taking sys-
temic corticosteroids. It may occur with extremely
variable forms of seriousness, from asymptomatic pul-
monary infiltrates to acute respiratory distress syndrome
associated with respiratory insufficiency. The possible
causes, such as drugs or parasitic infections, have been
widely studied, but are, in most cases, idiopathic [6]. In
our opinion, in accordance with the findings of other
Figure 2 Histological images. Transbronchial biopsies showed
several eosinophils associated with fibrin (hematoxylin and eosin
stain, 200×).
Figure 3 Histological images.F o c a l l y ,h y a l i n em e m b r a n e sw e r e
present (hematoxylin and eosin stain, 200×).
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better outcome of pneumonia with severe respiratory
distress; however it could determine a delayed onset of
eosinophilic pneumonia.
In our patient, we are inclined to consider it as having
an iatrogenic etiopathogenesis. Other causes were
excluded by laboratory tests for differential diagnosis
options (serum total and specific IgE, fecal and serologic
examinations for parasite infections).
Eosinophilic pneumonia has been linked to more than
80 drugs, although only 20 of these (for the most part
NSAIDs and antibiotics) can be considered as common
causes of this pathology [6]. All the drugs administered in
the weeks prior to the appearance of eosinophilic infiltrate
should be suspected as a possible cause of the pathology.
Iatrogenic eosinophilic infiltrates usually develop progres-
sively, with dyspnea, cough and fever in subjects who have
taken certain drugs for weeks or months.
The diagnosis of drug-induced eosinophilic pneumo-
nia is mainly based on a detailed history of drug expo-
sure, evidence of eosinophil accumulation in the lung
and exclusion of other causes. Numerous methods have
been studied in order to demonstrate sensitivity to one
or more drugs. One of the most commonly applied
methods is the lymphocyte stimulation test (LST),
which measures the proliferation of T lymphocytes in
response to a drug in vitro, in order to diagnose a pre-
vious reaction in vivo.T h i sc o n c e p tw a sc o n f i r m e db y
the finding of drug-specific T lymphocyte clones that
can interact with cellular receptors without being meta-
bolized and without bonding to protein carriers [8].
We did not consider it necessary to carry out the LST
with our patient because this method is not specific and
sensitive, and it has the major drawback of being diffi-
cult to interpret [8].
With regard to the challenge test in vivo, this was not
performed because of the serious clinical condition of
our patient, who in any case did not give his consent.
However, voluntary challenge may cause life-threatening
adverse reactions and it should be limited to rare situa-
tions [9].
Among the possible causes we considered, the first
was levofloxacin. There are some reports in the litera-
ture regarding the possibility of development of eosino-
philic pneumonia during the course of levofloxacin
therapy [4]; moreover, it was the drug administered to
our patient for the greatest number of days (21 in total).
Other points can be taken into account: (1) the drug
was suspended for four days in order to allow for wash-
out and subsequent blood culture; afterwards, the same
drug was resumed. At the same time, the clinical radi-
ological findings became worse, with an unintentional
challenge effect. (2) The BAL on the 22nd day, as some
other authors have reported, still showed compatibility
with ARDS Legionella, [10] while the following BAL
showed eosinophilia (28%) compatible with an acute
eosinophilic pneumonia [6], which histological exams
confirmed (Figure 3).
With regard to the other drugs administered, there are
reports of isolated cases of eosinophilia associated with
parenchymal infiltrates as a consequence of rifampicin
therapy [11]. There is only one reported case where
clarithromycin may have led to eosinophilic pneumonia
[12], but our patient was only treated with this drug for
two days. Moreover, it is possible that eosinophilic
pneumonia could be an adverse reaction to smoking in
predisposed subjects: this sometimes happens to patients
who have recently started smoking or who have modi-
fied their ‘way’ of smoking (for example, increasing or
changing type of smoking). Our patient, however, did
not report any changes, either in quantity or in quality,
in his smoking habits, so this would seem to exclude
any relation to smoking [13].
However, it is plausible that smoking could have acted
as a cofactor (together with the drugs) in triggering the
clinical condition, because it is a known fact that acute
eosinophilic infiltrates are often frequent in smokers
[14].
Conclusion
In conclusion, levofloxacin may be the most probable
cause of the occurrence of acute eosinophilic infiltrate
in this patient. It is important to emphasize that we
decided to change the diagnostic and therapeutic
approach only when the presence of eosinophilic infil-
trate was proven by transbronchial biopsy. Published
studies dealing with risks of invasive endoscopic
Figure 4 Chest X-ray. Thickening areas and parenchymal distortion
can be seen on the left upper lobe. Diffuse thickening can be seen
on medial and lower lobes (arrow).
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mechanical ventilation showed a higher incidence of
complications such as hemorrhage and pneumothorax.
Correlating the endoscopic risk to the percentage of
correctly carried out diagnoses, which varies from 33%
to 76%, with consequent change in therapeutic strategy,
it may be stated that the risk/benefit ratio of the endo-
scopic procedure in terms of therapeutic response is
surely in its favor and it is, therefore, recommended
[15].
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